Solid Biosciences (SLDB) Other Non-Current Assets (2017 - 2026)

Solid Biosciences has disclosed Other Non-Current Assets across 10 years of filings, most recently posting $708000.0 for Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $708000.0, down 64.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $708000.0 (down 64.12% YoY), and the FY2025 annual result was $768000.0, down 60.66% from the prior year.
• Other Non-Current Assets came in at $708000.0 for Q1 2026 at Solid Biosciences, down from $768000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $2.1 million in Q1 2022 to a low of $209000.0 in Q4 2023.
• The 5-year median for Other Non-Current Assets is $1.8 million (2022), against an average of $1.7 million.
• Across the five-year window, Other Non-Current Assets sank 88.6% in 2023 and surged 833.97% in 2024, its largest moves.
• Solid Biosciences' Other Non-Current Assets stood at $1.8 million in 2022, then tumbled by 88.6% to $209000.0 in 2023, then soared by 833.97% to $2.0 million in 2024, then slumped by 60.66% to $768000.0 in 2025, then retreated by 7.81% to $708000.0 in 2026.
• The last three Other Non-Current Assets figures came in at $708000.0 (Q1 2026), $768000.0 (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.